Researcher
Johan Vansteenkiste
- Disciplines:Respiratory medicine
Affiliations
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Oct 1999 → 30 Sep 2022
Projects
1 - 3 of 3
- Refining the role of dual checkpoint inhibition in advanced lung cancer: a single-cell approachFrom5 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- A single-cell approach to identify biomarkers of efficacy and toxicity for immune checkpoint blockade in non-small cell lung cancer.From1 Aug 2019 → 1 Aug 2023Funding: FWO Strategic Basic Research Grant, Foundations, funds and other with scientific goal
- Unraveling the common genetic basis for COPD, emphysema and lung cancer.From1 Aug 2010 → 16 Dec 2015Funding: Private funding of national origin - undefined, FWO fellowships
Publications
261 - 270 of 278
- Is Esophageal Ultrasound-Guided Fine Needle Aspiration the Last Stop on the Road to Accurate Mediastinal Staging?(2009)
Authors: Christophe Dooms, Johan Vansteenkiste
Pages: 371 - 372 - Survival after resection of synchronous bilateral lung cancer(2008)
Authors: Paul De Leyn, Johnny Moons, Johan Vansteenkiste, Erik Verbeken, Dirk Van Raemdonck, Philippe Nafteux, Herbert Decaluwé, Toni Lerut
Pages: 1215 - 1222 - Survival after resection of synchronous bilateral lung cancer(2008)
Authors: Paul De Leyn, Johnny Moons, Johan Vansteenkiste, Erik Verbeken, Dirk Van Raemdonck, Philippe Nafteux, Herbert Decaluwé, Toni Lerut
Pages: 1215 - 1222 - Respiratory oncology(2008)
Authors: Johan Vansteenkiste
Pages: 168 - 169 - Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: How CONSORTed are the data?(2008)
Authors: Christophe Dooms, Johan Vansteenkiste
Pages: 126 - 138 - Survival after resection of synchronous bilateral lung cancer(2008)
Authors: Paul De Leyn, Johnny Moons, Johan Vansteenkiste, Erik Verbeken, Dirk Van Raemdonck, Philippe Nafteux, Herbert Decaluwé, Toni Lerut
Pages: 1215 - 1222 - Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer(2008)
Authors: Johan Vansteenkiste, Eric Van Cutsem, Herlinde Dumez, Patrick Schöffski
Pages: 483 - 488 - Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer(2008)
Authors: Johan Vansteenkiste
Pages: 894 - 901 - Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer(2008)
Authors: Yolande Lievens, Erik Verbeken, Johan Vansteenkiste
Pages: 662 - 663 - Second-line treatment of advanced non-small cell lung cancer(2008)
Authors: Johan Vansteenkiste
Pages: 430 - 440